CLINICAL_TRIALS
trial_result
· 2025-12-02
Clinical Trial Update: Study of Efficacy and Safety of Secukinumab in Participants With Moderate-severe Rotator Cuff Tendinopathy [Phase 3]
Summary
The Phase 3 trial of secukinumab for moderate-severe rotator cuff tendinopathy was terminated, and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Rotator Cuff Tendinopathy | Phase 3 | Status: TERMINATED | Results posted: 2025-12-02